HUIZENGA THEODORE ALAN (SVP, Chief Accounting Officer) sold 0.2% of their position (161.00 shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $2.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/8/2026ACC: 0001193125-26-384878
Officer· SVP, Chief Accounting Officer
Since Mar 2026
-161.00
Net shares
Net seller
$2.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
161.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−161.00
Price / share
$13.99
Trade value
$2.25K
% of position
0.2%
9/3/2026
69.31K→69.15K
Total
Net shares
−161.00
Net value
-$2.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/3/2026 | S · Sale | −161.00 | $13.99 | $2.25K | 0.2% | 69.31K | 69.15K |
| Total | −161.00 | -$2.25K | ||||||
Derivative Transactions0
No derivative transactions reported